This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Source
Drug Enforcement Administration (DEA)
File Size
148 KB KB
Year
Format
Fact Sheet/Brochure
Terms of Use
Public domain
Topic
Regulations & Recordkeeping
Medication Considerations
Prescribing Opioids
Intake & Induction
Program Policies & Procedures
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Resource Type
PDF
Use
Substance Use Disorder Awareness and Education
Special Collection
MAT Tools and Resources
